Researchers Find How Natural Killer Cells Regulate Protective HIV Antibodies The finding advances efforts to develop a vaccine that elicits protective HIV antibodies
Duke-Led Team Develops More Accurate Tool to Track New HIV Infections Population-based model would benefit research and public health initiatives worldwide
Duke Institute Tapped to Build a Rapid-Response System for Viral Pandemics Existing components at the Duke Human Vaccine Institute form the effort’s infrastructure
Investigational Vaccine Protected Monkeys from HIV-Like Virus The vaccine adds three more targets to a human vaccine candidate that showed promise
Researchers Map Pathways to Protective Antibodies for an HIV Vaccine The findings advance progress toward HIV vaccine design
